No Data
On April 24, CHINA RISUN GP (01907.HK) spent 1.9 million Hong Kong dollars to repurchase 0.754 million shares.
Gelonghui reported on April 24 that CHINA RISUN GP (01907.HK) announced it repurchased 0.754 million shares at a cost of HKD 1.9 million on April 24.
On April 22, CHINA RISUN GP (01907.HK) spent 1.24 million Hong Kong dollars to repurchase 0.493 million shares.
On April 22, Gelonghui reported that CHINA RISUN GP (01907.HK) announced the repurchase of 0.493 million shares at a cost of 1.24 million Hong Kong dollars.
CHINA RISUN GP spent 5.1233 million Hong Kong dollars to repurchase 1.989 million shares on April 15.
CHINA RISUN GP (01907) announced the repurchase of 1.989 million shares at a cost of 5.1233 million Hong Kong dollars on April 15, 2025.
Hong Kong Stock Movement | CHINA RISUN GP (01907) rose over 5% in the last trading hours, with the company's controlling stake in Yihuatong expected to further expand the hydrogen energy industry landscape.
CHINA RISUN GP (01907) surged over 5% in the late session, as of the report, it rose by 4.86%, quoted at 2.59 Hong Kong dollars, with a trading volume of 28.0846 million Hong Kong dollars.
CITIC SEC: Maintain "Buy" rating for CHINA RISUN GP (01907) with a Target Price of 3 Hong Kong dollars.
In the field of hydrogen energy, the company plans to strengthen the integration of dual industries by holding a stake in Yihua Tong, which is expected to further expand the hydrogen energy industry's landscape.
Hong Kong stock announcement for gold mining | The serum-free iterative rabies vaccine developed by Ai Mei has been accepted for listing registration.
Aluminum Corporation Of China (02600) expects the net income attributable to shareholders in the first quarter to increase by 53% to 63% year-on-year...
Earnings Troubles May Signal Larger Issues for China Risun Group (HKG:1907) Shareholders
